Cargando…
Tumour location within the breast: Does tumour site have prognostic ability?
INTRODUCTION: Tumour location within the breast varies with the highest frequency in the upper outer quadrant (UOQ) and lowest frequency in the lower inner quadrant (LIQ). Whether tumour location is prognostic is unclear. To determine whether tumour location is prognostic, associations between tumou...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cancer Intelligence
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4531129/ https://www.ncbi.nlm.nih.gov/pubmed/26284116 http://dx.doi.org/10.3332/ecancer.2015.552 |
_version_ | 1782384990407884800 |
---|---|
author | Rummel, Seth Hueman, Matthew T Costantino, Nick Shriver, Craig D Ellsworth, Rachel E |
author_facet | Rummel, Seth Hueman, Matthew T Costantino, Nick Shriver, Craig D Ellsworth, Rachel E |
author_sort | Rummel, Seth |
collection | PubMed |
description | INTRODUCTION: Tumour location within the breast varies with the highest frequency in the upper outer quadrant (UOQ) and lowest frequency in the lower inner quadrant (LIQ). Whether tumour location is prognostic is unclear. To determine whether tumour location is prognostic, associations between tumour site and clinicopathological characteristics were evaluated. MATERIALS AND METHODS: All patients enrolled in the Clinical Breast Care Project whose tumour site—UOQ, upper inner quadrant (UIQ), central, LIQ, lower outer quadrant (LOQ)—was determined by a single, dedicated breast pathologist were included in this study. Patients with multicentric disease (n = 122) or tumours spanning multiple quadrants (n = 381) were excluded from further analysis. Clinicopathological characteristics were analysed using chi-square tests for univariate analysis with multivariate analysis performed using principal components analysis (PCA) and multiple logistic regression. Significance was defined as P < 0.05. RESULTS: Of the 980 patients with defined tumour location, 30 had bilateral disease. Tumour location in the UOQ (51.5%) was significantly higher than in the UIQ (15.6%), LOQ (14.2%), central (10.6%), or LIQ (8.1%). Tumours in the central quadrant were significantly more likely to have higher tumour stage (P = 0.003) and size (P < 0.001), metastatic lymph nodes (P < 0.001), and mortality (P = 0.011). After multivariate analysis, only tumour size and lymph node status remained significantly associated with survival. CONCLUSIONS: Evaluation of tumour location as a prognostic factor revealed that although tumours in the central region are associated with less favourable outcome, these associations are not independent of location but rather driven by larger tumour size. Tumours in the central region are more difficult to detect mammographically, resulting in larger tumour size at diagnosis and thus less favourable prognosis. Together, these data demonstrate that tumour location is not an independent prognostic factor. |
format | Online Article Text |
id | pubmed-4531129 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Cancer Intelligence |
record_format | MEDLINE/PubMed |
spelling | pubmed-45311292015-08-17 Tumour location within the breast: Does tumour site have prognostic ability? Rummel, Seth Hueman, Matthew T Costantino, Nick Shriver, Craig D Ellsworth, Rachel E Ecancermedicalscience Research INTRODUCTION: Tumour location within the breast varies with the highest frequency in the upper outer quadrant (UOQ) and lowest frequency in the lower inner quadrant (LIQ). Whether tumour location is prognostic is unclear. To determine whether tumour location is prognostic, associations between tumour site and clinicopathological characteristics were evaluated. MATERIALS AND METHODS: All patients enrolled in the Clinical Breast Care Project whose tumour site—UOQ, upper inner quadrant (UIQ), central, LIQ, lower outer quadrant (LOQ)—was determined by a single, dedicated breast pathologist were included in this study. Patients with multicentric disease (n = 122) or tumours spanning multiple quadrants (n = 381) were excluded from further analysis. Clinicopathological characteristics were analysed using chi-square tests for univariate analysis with multivariate analysis performed using principal components analysis (PCA) and multiple logistic regression. Significance was defined as P < 0.05. RESULTS: Of the 980 patients with defined tumour location, 30 had bilateral disease. Tumour location in the UOQ (51.5%) was significantly higher than in the UIQ (15.6%), LOQ (14.2%), central (10.6%), or LIQ (8.1%). Tumours in the central quadrant were significantly more likely to have higher tumour stage (P = 0.003) and size (P < 0.001), metastatic lymph nodes (P < 0.001), and mortality (P = 0.011). After multivariate analysis, only tumour size and lymph node status remained significantly associated with survival. CONCLUSIONS: Evaluation of tumour location as a prognostic factor revealed that although tumours in the central region are associated with less favourable outcome, these associations are not independent of location but rather driven by larger tumour size. Tumours in the central region are more difficult to detect mammographically, resulting in larger tumour size at diagnosis and thus less favourable prognosis. Together, these data demonstrate that tumour location is not an independent prognostic factor. Cancer Intelligence 2015-07-13 /pmc/articles/PMC4531129/ /pubmed/26284116 http://dx.doi.org/10.3332/ecancer.2015.552 Text en © the authors; licensee ecancermedicalscience. http://creativecommons.org/licenses/by/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Rummel, Seth Hueman, Matthew T Costantino, Nick Shriver, Craig D Ellsworth, Rachel E Tumour location within the breast: Does tumour site have prognostic ability? |
title | Tumour location within the breast: Does tumour site have prognostic ability? |
title_full | Tumour location within the breast: Does tumour site have prognostic ability? |
title_fullStr | Tumour location within the breast: Does tumour site have prognostic ability? |
title_full_unstemmed | Tumour location within the breast: Does tumour site have prognostic ability? |
title_short | Tumour location within the breast: Does tumour site have prognostic ability? |
title_sort | tumour location within the breast: does tumour site have prognostic ability? |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4531129/ https://www.ncbi.nlm.nih.gov/pubmed/26284116 http://dx.doi.org/10.3332/ecancer.2015.552 |
work_keys_str_mv | AT rummelseth tumourlocationwithinthebreastdoestumoursitehaveprognosticability AT huemanmatthewt tumourlocationwithinthebreastdoestumoursitehaveprognosticability AT costantinonick tumourlocationwithinthebreastdoestumoursitehaveprognosticability AT shrivercraigd tumourlocationwithinthebreastdoestumoursitehaveprognosticability AT ellsworthrachele tumourlocationwithinthebreastdoestumoursitehaveprognosticability |